Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shelter PharmaBOM:543963 -3.82%69 3-Year ROIIC % is 4.85 as of Mar. 2026, which is 79% below its 10-year median of 22.83. GuruFocus rates BOM:543963 with a GF Score™ of 69/100 and a GF Value™ of ₹57.41 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 944 Drug Manufacturers companies, Shelter Pharma ranks better than 51.38% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Shelter Pharma's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was 4.85%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Shelter Pharma's 3-Year ROIIC % or its related term are showing as below:
BOM:543963's 3-Year ROIIC % is ranked better than 51.38% of 944
companies
in the Drug Manufacturers industry
Industry Median: 3.565
vs BOM:543963: 4.85
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Shelter Pharma 3-Year ROIIC % Related Terms
Shelter Pharma 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Shelter Pharma's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Shelter Pharma's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shelter Pharma 3-Year ROIIC % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shelter Pharma's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Shelter Pharma's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Shelter Pharma (BOM:543963) has a 3-Year ROIIC % of 4.85 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Shelter Pharma and its competitors. This is 79% below median its historical median of 22.83. Over the past decade, Shelter Pharma's 3-Year ROIIC % has ranged from 4.85 to 56.35. According to the industry distribution chart, Shelter Pharma ranks #459 out of 944 companies in the Drug Manufacturers industry, placing it in the top 48.6%.
Is Shelter Pharma's 3-Year ROIIC % too high?
Shelter Pharma's current 3-Year ROIIC % of 4.85 is 79% below median its 10-year median of 22.83. Over the past 10 years, this metric has ranged from a low of 4.85 to a high of 56.35. The Drug Manufacturers industry median 3-Year ROIIC % is 3.57. Shelter Pharma's value of 4.85 is 36% above this industry median. Based on the distribution chart, Shelter Pharma ranks #459 out of 944 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Shelter Pharma has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shelter Pharma's 3-Year ROIIC % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Shelter Pharma ranks #459 out of 944 companies for 3-Year ROIIC %. This puts Shelter Pharma in the upper half of its industry. The industry median 3-Year ROIIC % is 3.57. Shelter Pharma's value of 4.85 is 36% above this benchmark. Historically, Shelter Pharma's own 3-Year ROIIC % has ranged from 4.85 to 56.35 over the past decade. While the company's 10-year median is 22.83 vs. the industry median of 3.57, Shelter Pharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Drug Manufacturers company?
The median 3-Year ROIIC % among Drug Manufacturers companies is 3.57, based on 944 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shelter Pharma's current 3-Year ROIIC % of 4.85 is 36% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Shelter Pharma and its competitors. For the Drug Manufacturers industry, the median 3-Year ROIIC % is 3.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shelter Pharma's current 3-Year ROIIC % is 4.85, which is 79% below median its own 10-year median of 22.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shelter Pharma stock overvalued right now?
Based on GuruFocus' analysis, Shelter Pharma (BOM:543963) is currently considered Possible Value Trap. The stock's GF Value™ is ₹57.41, compared to a current price of ₹31.50 — trading 45.1% below its estimated fair value. The current 3-Year ROIIC % is 4.85, which is 79% below median its 10-year median of 22.83 and 36% above the Drug Manufacturers industry median of 3.57. Shelter Pharma's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Shelter Pharma (BOM:543963), the current 3-Year ROIIC % is 4.85 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shelter Pharma (BOM:543963) Overvalued in 2026?
Based on GuruFocus' analysis, Shelter Pharma stock appears to be undervalued.
The current stock price of ₹31.50 is trading 45.1% below its estimated GF Value™ of ₹57.41.
GuruFocus considers Shelter Pharma to be Possible Value Trap.
Key valuation signals for BOM:543963:
3-Year ROIIC %: 4.85 (79% below median its 10-year median of 22.83)
GF Value™: ₹57.41 vs. price of ₹31.50 (45.1% below fair value)
Industry Position: 36% above the Drug Manufacturers median (#459 of 944)
No single metric tells the full story. See the BOM:543963 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shelter Pharma Ltd focuses in manufacturing herbal products with a well-built presence in Human Pharma as well as the Veterinary space. It is present in majority of the non-critical segments of human and veterinary pharma through its well-spread portfolio. Its products include tablets, syrups, baby drops, barley water, oils, powders, ointments, etc.
69GF Score
Get the complete analysis for BOM:543963
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543963 has been successfully added to your 
